ARTIDIS AG

ARTIDIS AG is a clinical-stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. By combining its proprietary nanotechnology platform for rapid tissue analysis with a holistic data solution, ARTIDIS accelerates drug discovery, tissue engineering, and personalized treatment. The company focuses its research and development efforts on solid tumors to enhance responses to chemotherapy, immunotherapy, and cell therapies, driving precision in cancer care.